Detalhe da pesquisa
1.
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.
N Engl J Med
; 375(9): 819-29, 2016 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27433843
2.
Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer.
Cancer Med
; 13(9): e7212, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38686626
3.
Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses.
Proc Natl Acad Sci U S A
; 107(32): 14286-91, 2010 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20624956
4.
Characterization of T Follicular Helper Cells and T Follicular Regulatory Cells in HIV-Infected and Sero-Negative Individuals.
Cells
; 12(2)2023 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36672230
5.
Antitumor Immune Responses in B2M-Deficient Cancers.
Cancer Immunol Res
; 11(12): 1642-1655, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801341
6.
Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade.
J Immunother Cancer
; 11(5)2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37156551
7.
Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy.
Cancer Immunol Res
; 11(12): 1589-1597, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871333
8.
High Interferon Signature Leads to Increased STAT1/3/5 Phosphorylation in PBMCs From SLE Patients by Single Cell Mass Cytometry.
Front Immunol
; 13: 833636, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35185925
9.
Remodeling of the tumor microenvironment through PAK4 inhibition sensitizes tumors to immune checkpoint blockade.
Cancer Res Commun
; 2(10): 1214-1228, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588582
10.
Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects.
PLoS One
; 16(6): e0252597, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161353
11.
Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032.
J Transl Med
; 8: 39, 2010 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20406486
12.
CD4+CD25- T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in a human melanoma model.
J Immunol
; 181(2): 1063-70, 2008 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18606658
13.
Intratumoral immune cell infiltrates, FoxP3, and indoleamine 2,3-dioxygenase in patients with melanoma undergoing CTLA4 blockade.
Clin Cancer Res
; 15(1): 390-9, 2009 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19118070
14.
Epigenetic Suppression of Transgenic T-cell Receptor Expression via Gamma-Retroviral Vector Methylation in Adoptive Cell Transfer Therapy.
Cancer Discov
; 10(11): 1645-1653, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32699033
15.
A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma.
J Immunother
; 43(9): 273-282, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32925563
16.
PAK4 inhibition improves PD-1 blockade immunotherapy.
Nat Cancer
; 1(1): 46-58, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-34368780
17.
Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade.
Cancer Discov
; 10(8): 1140-1157, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32467343
18.
Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist.
Nat Commun
; 11(1): 660, 2020 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32005809
19.
A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab.
Clin Cancer Res
; 25(7): 2096-2108, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30573690
20.
Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma.
J Transl Med
; 6: 22, 2008 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18452610